Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in brain tumours. Part 2 of 2.
Questions
1. What are the most promising agents targeting molecular pathways in brain metastases? (0:12)
2. What are the current limitations of the personalised medicine approach and how may these be overcome? (1:45)
View Part 1 here.
Speaker disclosure: Riccardo Soffietti has nothing to disclose in relation to this video interview.
Filmed at the 4th Congress of the European Academy of Neurology (EAN), Lisbon, Portugal, June 2018.
